Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Programmed Death Ligand 1 (PD-L1) positivity rates differ between different metastatic sites and the primary tumor. Understanding PD-L1 expression characteristics could guide biopsy procedures and motivate research to better understand site-specific differences in the tumor microenvironment. The pur...

Full description

Bibliographic Details
Main Authors: Brian Alexander, Lajos Pusztai, David L Rimm, Priti Hegde, Mariya Rozenblit, Richard Huang, Natalie Danziger, Shakti Ramkissoon, Kim Blenman, Jeffrey S Ross
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001558.full

Internet

https://jitc.bmj.com/content/8/2/e001558.full

Similar Items